Skip to content

13F-HR filed by Vivo Capital, LLC

Vivo Capital, LLC filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 51 holding rows worth $905,810,000.

Accession
0001213900-22-072092
Filed
2022-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2022

A holdings report, 51 entries on the cover page, a total value of $905,810,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $905,807,000 with VALUE read as thousands by filing date, 13F file number 028-17467. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
HARMONY BIOSCIENCES HLDGS IN413197104COM3,400,261$150,598,000thousands by filing date
Instil Bio, Inc.45783C101Common Stock12,486,787$60,436,000thousands by filing date
Ventyx Biosciences Inc92332V107Common Stock1,355,861$47,333,000thousands by filing date
VERONA PHARMA PLC925050106SPONSORED ADS4,249,918$43,434,000thousands by filing date
ALX ONCOLOGY HOLDINGS INC00166B105COMMON STOCK4,220,048$40,386,000thousands by filing date
TARSUS PHARMACEUTICALS INC87650L103COMMON STOCK2,262,200$38,729,000thousands by filing date
SINOVAC BIOTECH LTDP8696W104SHS5,900,000$38,173,000thousands by filing date
GERON CORP374163103COM15,238,095$35,657,000thousands by filing date
TERNS PHARMACEUTICALS INC COM880881107Stock5,899,372$34,747,000thousands by filing date
VIRIDIAN THERAPEUTICS INC92790C104COM1,660,019$34,047,000thousands by filing date
COGENT BIOSCIENCES INC19240Q201COM1,883,941$28,108,000thousands by filing date
RELMADA THERAPEUTICS INC75955J402COMMON STOCK713,238$26,404,000thousands by filing date
ALLAKOS INC01671P100COM4,120,134$25,215,000thousands by filing date
AMYRIS INC03236M200COM NEW7,750,828$22,632,000thousands by filing date
KALVISTA PHARMACEUTICALS INC483497103COM1,533,559$22,252,000thousands by filing date
CHINOOK THERAPEUTICS INC16961L106COM872,151$17,146,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR146,025$15,079,000thousands by filing date
AVADEL PHARMACEUTICALS, PLC05337M104COMMON STOCK-FO2,937,093$14,715,000thousands by filing date
VERA THERAPEUTICS INC92337R101COMMON STOCK666,666$14,207,000thousands by filing date
ACLARIS THERAPEUTICS INC COM00461U105Stock898,631$14,144,000thousands by filing date
IMPEL PHARMACEUTICALS INC45258K109CMN2,884,789$14,049,000thousands by filing date
CINCOR PHARMA INC17240Y109COM349,237$11,462,000thousands by filing date
BELLUS HEALTH INC NEW07987C204COM1,017,152$10,741,000thousands by filing date
LEGEND BIOTECH CORP52490G102SPONSORED ADS244,375$9,971,000thousands by filing date
VAXCYTE INC COM92243G108Stock404,508$9,708,000thousands by filing date
ZAI LAB LTD ADR98887Q104ADR271,528$9,286,000thousands by filing date
ASTRIA THERAPEUTICS INC COM04635X102Stock1,000,000$9,040,000thousands by filing date
MERUS N VN5749R100COM442,000$8,853,000thousands by filing date
IVERIC BIO INC46583P102COM483,413$8,672,000thousands by filing date
IO BIOTECH INC449778109COM3,015,545$8,172,000thousands by filing date
SATSUMA PHARMACEUTICALS INC80405P107COM1,232,394$7,394,000thousands by filing date
DYNE THERAPEUTICS INC COM26818M108Stock577,642$7,336,000thousands by filing date
WHITEHAWK THERAPEUTICS INC00032Q104CMN509,572$7,200,000thousands by filing date
GENETRON HLDGS LTD37186H100ADS8,124,174$6,351,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM655,057$6,275,000thousands by filing date
BOLT BIOTHERAPEUTICS INC097702104COM3,871,291$5,730,000thousands by filing date
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW198,983$5,593,000thousands by filing date
DBV TECHNOLOGIES S A23306J101ADR2,708,875$4,795,000thousands by filing date
OLEMA PHARMACEUTICALS INC68062P106COM1,689,515$4,663,000thousands by filing date
COMPASS THERAPEUTICS INC20454B104COM2,000,000$4,560,000thousands by filing date
ARROWHEAD PHARMACEUTICALS IN04280A100COM137,411$4,541,000thousands by filing date
ALIGOS THERAPEUTICS INC COM NEW01626L105Stock3,547,030$3,902,000thousands by filing date
GRACELL BIOTECHNOLOGIES INC38406L103ADR961,359$3,096,000thousands by filing date
SERA PROGNOSTICS INC81749D107CMN1,856,011$2,970,000thousands by filing date
CODEXIS INC192005106COM388,144$2,352,000thousands by filing date
MINERVA SURGICAL INC60343F106COM2,215,667$1,762,000thousands by filing date
ASLAN PHARMACEUTICALS LTD04522R101ADR2,840,909$1,701,000thousands by filing date
REZOLUTE INC76200L309COMMON STOCK489,473$1,341,000thousands by filing date
TRANSPORTATION & LOGISTI438083107COM370,068$596,000thousands by filing date
PRECISION BIOSCIENCES INC74019P108COM140,255$182,000thousands by filing date
METACRINE INC59101E103COM146,426$71,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001213900-22-072092this filing2022-11-14acceptance time not in the bulk data set